Time to Fibrinolytic Therapy for Acute Myocardial Infarction - Meel, Ruchika;Gonçalves, Ricardo
22,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
payback
11 °P sammeln
  • Broschiertes Buch

Fibrinolytic therapy is a time critical intervention proven to reduce mortality and morbidity in patients with acute ST elevation myocardial infarction (STEMI). Limited data exists in South Africa regarding time to fibrinolytic therapy for STEMI patients and reasons for delayed therapy. We established the frequency of fibrinolytic therapy administration to patients presenting with STEMI to a single, urban center in Pretoria, South Africa. Furthermore, we identified reasons for delays in receiving fibrinolytic agents. We suggest potential solutions to address the myriad of challenges facing our country in this regard.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Fibrinolytic therapy is a time critical intervention proven to reduce mortality and morbidity in patients with acute ST elevation myocardial infarction (STEMI). Limited data exists in South Africa regarding time to fibrinolytic therapy for STEMI patients and reasons for delayed therapy. We established the frequency of fibrinolytic therapy administration to patients presenting with STEMI to a single, urban center in Pretoria, South Africa. Furthermore, we identified reasons for delays in receiving fibrinolytic agents. We suggest potential solutions to address the myriad of challenges facing our country in this regard.
Autorenporträt
Ruchika Meel qualified as a cardiologist in 2013 and completed her PhD in 2016. Her interests include ischemic and valvular heart disease, and non-invasive imaging.Ricardo Gonçalves qualified as a cardiologist in 2011. His interests include interventional cardiology, syncope and heart failure.Both work as clinical cardiologists in Johannesburg.